• 1. Fe/Fe3C@C nanoparticles encapsulated in N-doped graphene–CNTs framework as an efficient bifunctional oxygen electrocatalyst for robust rechargeable Zn–air batteries?
  Zhiyan Chen,Nan Wu,Yaobing Wang,Bing Wang,Yingde Wang J. Mater. Chem. A, 2018,6, 516-526
• 2. Exchanged ligands on the surface of a giant cluster: [(MoO3)176(H2O)63(CH3OH)17Hn](32 – n)–
  Chem. Commun., 1998, 1501-1502
• 3. Fc microparticles can modulate the physical extent and magnitude of complement activity?
  David White,Sean R. Stowell Biomater. Sci., 2017,5, 463-474
• 4. Emergence of microfluidic wearable technologies
  Joo Chuan Yeo,Kenry Lab Chip, 2016,16, 4082-4090
• 5. Enabling shape memory and healable effects in a conjugated polymer by incorporating siloxane via dynamic imine bond?
  Yaling Zhang,Chunhui Dai,Shiwei Zhou,Bin Liu Chem. Commun., 2018,54, 10092-10095

• Solvents and Organic Chemicals Organic Compounds Organoheterocyclic compounds Triazines Triazinethiones

1,2,4-Triazin-5(2H)-one Derivative (CAS No. 22278-76-8): Structural Insights and Emerging Applications in Chemical Biology

The compound 1,2,4-triazin-5(2H)-one, specifically the 4-amino-6-ethyl-3,4-dihydro-3-thioxo variant (CAS No. 22278-76-8), represents a structurally unique triazine-based scaffold with significant potential in pharmaceutical and biochemical research. This molecule combines the inherent reactivity of the thioxo group at position 3 with substituents such as the amino group at C4 and an ethyl substituent at C6 to create a versatile platform for functionalization. Recent advancements in computational chemistry and synthetic methodologies have revitalized interest in this compound's role as a bioactive template.

In its core structure (1,2,4-triazine ring system), the dihydrothioxo moiety introduces a polarizable sulfur atom that enhances molecular flexibility and hydrogen bonding capabilities. These properties were experimentally validated through X-ray crystallography studies published in the Journal of Organic Chemistry (Qian et al., 2023), which revealed a planar conformation with optimal π-electron delocalization across the heterocyclic ring. The presence of the amino group further enables facile derivatization strategies for tuning pharmacokinetic profiles without compromising structural integrity.

Synthetic chemists have recently optimized protocols for preparing this compound using microwave-assisted techniques reported in Chemical Communications (Zhang & Lee, 2023). The authors demonstrated that employing N,N'-dicyclohexylcarbodiimide (DCC) mediated condensation under solvent-free conditions significantly improves yield compared to traditional reflux methods. This methodological breakthrough reduces reaction times by over 70% while maintaining product purity above 98%, as confirmed by NMR spectroscopy and mass spectrometry analysis.

Biochemical investigations have identified promising applications in enzyme inhibition studies. A collaborative study between MIT and Stanford researchers (Nature Chemical Biology, 2023) showed that this compound selectively binds to cysteine-rich domains of protein kinase C (PKC) isoforms with nanomolar affinity. The thioxo group's electrophilic character facilitates covalent attachment to target residues through Michael addition mechanisms without affecting non-cysteine containing enzymes. This selectivity makes it an ideal probe for studying PKC-dependent signaling pathways implicated in neurodegenerative diseases.

In drug discovery contexts (e.g., oncology research), this compound serves as a privileged structure for developing antiproliferative agents. A 2023 study published in European Journal of Medicinal Chemistry demonstrated its ability to inhibit histone deacetylase 6 (HDAC6) at submicromolar concentrations through an allosteric binding mechanism distinct from conventional HDAC inhibitors. The ethyl substituent plays a critical role in modulating cellular permeability while maintaining enzymatic specificity-a balance critical for successful drug candidates.

Surface plasmon resonance experiments conducted at Scripps Research Institute revealed novel binding interactions with human topoisomerase IIα (TopIIα). The triazine ring's planar geometry allows π-stacking interactions with aromatic residues within the enzyme's active site cleft while the amino group forms hydrogen bonds with key catalytic residues. This dual interaction mechanism explains its enhanced inhibitory activity compared to non-sulfur containing analogs studied previously.

Preliminary toxicity studies using zebrafish models (ACS Medicinal Chemistry Letters, 2023) indicated favorable safety profiles when administered at therapeutic concentrations. The compound exhibited no observable teratogenic effects up to 50 μM concentrations over a seven-day exposure period-a significant improvement over earlier triazine derivatives that demonstrated developmental toxicity at lower doses due to their rigid molecular frameworks.

The sulfur-containing thioxo functionality has enabled new applications in click chemistry reactions as reported by researchers at ETH Zurich (Chemical Science, 2023). By coupling this scaffold with azide-functionalized biomolecules under copper-free conditions (e.g., strain-promoted azide alkyne cycloaddition), they successfully created bioorthogonal probes for real-time imaging of protein-protein interactions in live cells without interference from endogenous molecules.

In recent metabolomics studies (Analytical Chemistry, 2023), this compound has been utilized as a derivatization agent for thiols and disulfides detection due to its high reactivity toward these functional groups under mild conditions. Its thioamide intermediate products provide superior ionization efficiency during mass spectrometry analysis compared to conventional reagents like dansyl chloride or iodoacetamide.

A groundbreaking application emerged from studies on metalloenzyme inhibition published in JACS Au. Researchers found that when coordinated with zinc ions through its thioxo sulfur atom, the compound forms stable complexes that effectively block carbonic anhydrase XII activity-a target linked to tumor acidosis regulation. This dual role as both metal chelator and enzyme inhibitor represents an innovative approach to multitarget drug design strategies currently gaining traction in medicinal chemistry circles.

Liquid chromatography-mass spectrometry (LC/MS) analysis of metabolic pathways showed rapid conversion into sulfenic acid derivatives under physiological conditions (Bioorganic & Medicinal Chemistry, pQ1:Q1-Q9). These metabolites retain pharmacological activity while demonstrating improved water solubility-an important consideration for parenteral drug delivery systems requiring high aqueous stability.

Innovative solid-state chemistry approaches are being explored using this compound's amphoteric nature discovered by crystallographic analysis (Inorganic Chemistry, pQ1:Q1-Q9). By combining it with layered double hydroxides via ion exchange methods, scientists have created nanocomposite materials capable of controlled release profiles extending up to seven days when tested against model drugs like doxorubicin-an advancement potentially useful for sustained drug delivery applications.

Raman spectroscopy studies conducted at Max Planck Institute revealed conformational changes occurring upon binding to serum albumins (Biochimica et Biophysica Acta, pQ1:Q1-Q9). These findings suggest possible use as fluorescent markers when conjugated with fluorophores through its amino group-a strategy validated by subsequent fluorescence correlation spectroscopy experiments showing quantum yields exceeding conventional triazine-based dyes by approximately threefold under physiological pH conditions.

New analytical methods utilizing this compound's UV-vis absorption characteristics are being developed for rapid detection of reactive oxygen species (ROS). Researchers from NUS demonstrated that when functionalized with phenolic groups via Suzuki coupling reactions (Talanta, pQ1:Q1-Q9), it forms redox-sensitive probes capable of detecting hydroxyl radicals with picomolar sensitivity under biologically relevant conditions-a critical advancement given ROS' role in cellular stress responses and disease progression mechanisms.

Cryogenic electron microscopy data recently published (Nature Structural & Molecular Biology, pQ1:Q1-Q9) provided atomic-level insights into how this scaffold interacts with epigenetic regulators like BRD4. The dihydrothioxo moiety inserts into hydrophobic pockets adjacent to bromodomain interfaces while the ethyl group stabilizes protein-ligand interactions through van der Waals forces-an interaction mode not previously observed among conventional benzodiazepine-based inhibitors used in similar contexts.

Synthetic biologists have incorporated this molecule into engineered metabolic pathways using CRISPR-Cas9 mediated gene editing techniques reported last year (Molecular Systems Biology,). By expressing enzymes capable of utilizing its thioamide intermediate form as a precursor molecule within yeast cells (Saccharomyces cerevisiae, strain BY4741), they achieved production yields exceeding natural analogs by nearly fourfold-an important step toward scalable biosynthesis processes requiring sulfur-containing intermediates without toxic side products.

New computational models developed using density functional theory (DFT) calculations predict favorable interactions between this scaffold and G-quadruplex DNA structures associated with cancer cell proliferation mechanisms (Bioinformatics,). Molecular docking simulations indicate binding energies between -8 kcal/mol and -9 kcal/mol depending on substituent orientation-a range comparable to clinically approved drugs targeting similar nucleic acid conformations but offering improved selectivity based on recent cell viability assays conducted across multiple cancer cell lines including MCF-7 and HeLa cells.

Polymer chemists have recently synthesized novel conjugated polymers incorporating this triazine derivative's backbone structure through Stille coupling reactions (Polymer Chemistry,). These materials exhibit tunable photoluminescence properties spanning visible wavelengths when tested under different solvent environments-a characteristic being explored for next-generation optogenetic tools requiring precise light modulation capabilities without photobleaching effects observed among traditional fluorophores used in cellular imaging applications.

• 2098070-20-1(2-(3-(Pyridin-3-yl)-1H-pyrazol-1-yl)acetimidamide)
• 2680771-01-9(4-cyclopentyl-3-{(prop-2-en-1-yloxy)carbonylamino}butanoic acid)
• 1444113-98-7(N-(3-cyanothiolan-3-yl)-2-[(2,2,2-trifluoroethyl)sulfanyl]pyridine-4-carboxamide)
• 332062-08-5(Fmoc-S-3-amino-4,4-diphenyl-butyric acid)
• 1270529-38-8(1,2,3,4,5,6-Hexahydro-[2,3]bipyridinyl-6-ol)
• 941977-17-9(N'-(3-chloro-2-methylphenyl)-N-2-(dimethylamino)-2-(naphthalen-1-yl)ethylethanediamide)
• 2138166-62-6(2,2-Difluoro-3-[methyl(2-methylbutyl)amino]propanoic acid)
• 89640-58-4(2-Iodo-4-nitrophenylhydrazine)
• 1449132-38-0(3-Fluoro-5-(2-fluoro-5-methylbenzylcarbamoyl)benzeneboronic acid)
• 2034271-14-0(2-(1H-indol-3-yl)-N-{[6-(thiophen-2-yl)-[1,2,4]triazolo[4,3-b]pyridazin-3-yl]methyl}acetamide)